Follow the Lyka Labs Limited stock price and the full insider trade history of the company, a publicly traded company based in India. Shares are listed on IN IN, under the supervision of SEBI (PIT + SAST). Operating in the Health Care sector, Lyka Labs Limited has published 23 reports. Market capitalisation: €2.1bn. The latest transaction was reported on 17 April 2024 (Purchase). Among the most active insiders: Nehal N. Gandhi. The full history is openly available.
23
Insider Decl.
0
Thresholds
€19m
19 ops.
Buy Volume
·
4 ops.
Sell Volume
6Σ signal
Buys €19m· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 19,075 of 25,791 companies
35.6
score / 100
Value
25
Quality
47
FCF yld-2.8%
Earn yld-4.8%
EV/EBITDA·
ROE·
Gross mgn61%
Net mgn-7.8%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.